Clearstead Advisors, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$56,565
-76.3%
5,0640.0%0.00%
-89.5%
Q2 2022$239,000
-33.6%
5,0640.0%0.02%
-20.8%
Q1 2022$360,000
-5.0%
5,0640.0%0.02%
-7.7%
Q4 2021$379,000
+31.6%
5,0640.0%0.03%
+23.8%
Q3 2021$288,000
+29.1%
5,0640.0%0.02%
+23.5%
Q2 2021$223,000
-10.8%
5,0640.0%0.02%
-19.0%
Q1 2021$250,000
+17.4%
5,0640.0%0.02%
+10.5%
Q4 2020$213,000
-8.2%
5,0640.0%0.02%
-24.0%
Q3 2020$232,000
-8.7%
5,0640.0%0.02%
-13.8%
Q2 2020$254,000
-2.3%
5,0640.0%0.03%
-23.7%
Q1 2020$260,000
-16.9%
5,0640.0%0.04%0.0%
Q4 2019$313,000
+3.0%
5,0640.0%0.04%
-7.3%
Q3 2019$304,000
-28.8%
5,0640.0%0.04%
-28.1%
Q2 2019$427,000
-11.8%
5,0640.0%0.06%
-14.9%
Q1 2019$484,000
+34.8%
5,0640.0%0.07%
+19.6%
Q4 2018$359,000
-17.1%
5,0640.0%0.06%
-5.1%
Q3 2018$433,000
-26.2%
5,0640.0%0.06%
-29.8%
Q2 2018$587,000
+43.2%
5,0640.0%0.08%
+42.4%
Q1 2018$410,000
+38.0%
5,0640.0%0.06%
+47.5%
Q4 2017$297,000
+25.3%
5,0640.0%0.04%
+29.0%
Q3 2017$237,0005,0640.03%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,055,719$35,367,00012.68%
GREAT POINT PARTNERS LLC 828,253$27,746,0005.70%
McClain Value Management LLC 116,153$3,891,0004.80%
Stonepine Capital Management, LLC 231,913$7,769,0004.63%
ARMISTICE CAPITAL, LLC 228,000$7,638,0001.81%
Opaleye Management Inc. 90,000$3,015,0001.78%
Matarin Capital Management, LLC 257,268$8,618,478,0000.97%
HAYS ADVISORY LLC 116,939$3,917,0000.87%
Granahan Investment Management 496,025$16,617,0000.57%
AlphaMark Advisors, LLC 33,000$1,106,0000.57%
View complete list of ENANTA PHARMACEUTICALS INC shareholders